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Abstract
Background: Voluntary contraceptive use by HIV-positive women currently prevents more HIV-positive births, at a lower
cost, than anti-retroviral drug (ARV) regimens. Despite this evidence, most prevention of mother-to-child transmission
(PMTCT) programs focus solely on providing ARV prophylaxis to pregnant women and rarely include the prevention of
unintended pregnancies among HIV-positive women.
Methodology/Principal Findings: To strengthen support for family planning as HIV prevention, we systematically identified
key individuals in the field of international HIV/AIDS—those who could potentially influence the issue—and sought to
determine their perceptions of barriers to and facilitators for implementing this PMTCT strategy. We used a criteria-based
approach to determine which HIV/AIDS stakeholders have the most significant impact on HIV/AIDS research, programs,
funding and policy and stratified purposive sampling to conduct interviews with a subset of these individuals. The interview
findings pointed to obstacles to strengthening linkages between family planning and HIV/AIDS, including the need for:
resources to integrate family planning and HIV services, infrastructure or capacity to provide integrated services at the
facility level, national leadership and coordination, and targeted advocacy to key decision-makers.
Conclusions/Significance: The individuals we identified as having regional or international influence in the field of HIV/AIDS
have the ability to leverage an increasingly conducive funding environment and a growing evidence base to address the
policy, programmatic and operational challenges to integrating family planning with HIV/AIDS. Fostering greater support
for implementing contraception for HIV prevention will require the dedication, collaboration and coordination of many such
actors. Our findings can inform a targeted advocacy campaign.
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Introduction
Ninety percent of new HIV infections among children under
age 15 are a result of mother-to-child transmission [1]. To address
this problem, the World Health Organization (WHO) and the
United Nations Joint Programme on HIV/AIDS (UNAIDS)
outlined a four-element strategy for the prevention of mother-to-
child transmission (PMTCT) of HIV (see Fig. 1).
Although linking family planning and HIV services is generally
considered feasible and effective [2,3,4] and despite the fact that
the contributions of contraception to reducing MTCT have been
well documented [5,6,7], the vast majority of PMTCT programs
continue to focus almost exclusively on providing antiretroviral
(ARV) prophylaxis to pregnant mothers and infants [8]. The
percentage of HIV-positive pregnant women who received ARV
treatment to prevent vertical transmission reached an average of
45% in 2008, up from 35% in 2007 [9]. Indeed, nearly 240,000
infant infections have been averted through ARV regimens
cumulatively over the past five years [10]. The steady progress
made in reaching pregnant women with ARV interventions is a
significant public health achievement. In comparison, however,
models project that current contraceptive use may already be
preventing more than 220,000 HIV-positive births per year in
countries hardest hit by the HIV epidemic [11,12]. By these
estimates, voluntary contraceptive use prevents more infants from
becoming infected with HIV than the more common intervention
of treating the mother and infant with ARVs. As these estimates
are based on current (low) contraceptive use in developing
countries, and as several studies have shown that women who
know they have HIV are less likely than other women to report
wanting additional children [13,14,15], efforts to alleviate current
unmet need for family planning (often high among HIV-infected
women [16,17,18]) could substantially increase the number of
HIV-positive births averted.
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from key influential individuals is critical to widespread
adoption of a new or underused idea or practice [19,20]. Such
individuals act as opinion leaders, and since they play key roles
in influencing HIV/AIDS decision-making and strategic
planning, may speed the diffusion of new ideas or practices
[21,22,23]. Based on these theories our project goals were: 1) to
identify the most influential individuals in the international
HIV/AIDS field–i.e., those who currently inform HIV/AIDS
funding, policy, programming and research; 2) to determine
their perceptions of the barriers to supporting or implementing
the strategy and factors that might facilitate its adoption; and 3)
to reach the influential individuals identified in the first step of
the process with a communications intervention that addressed
identified facilitators and barriers.
This paper focuses on the first two goals. We used criteria-based
searches to identify key opinion leaders in HIV/AIDS, and
through key informant interviews we explored their knowledge of
contraception as an effective PMCT strategy, and their perceived
facilitators and barriers to implementing element 2 of a
comprehensive PMTCT program.
Methods
Stakeholder Identification
To identify opinion leaders in HIV/AIDS we adapted a
stakeholder analysis methodology that focused on identifying
influential individuals [24]. We defined stakeholders as ‘‘all parties
who will be affected by or will affect’’ the issue [25]. We postulated
that different types of HIV stakeholders would be necessary to
‘‘tip’’ [20] the uptake of contraception as an HIV prevention
strategy. We focused on identifying stakeholders among groups
that have the most direct impact on HIV/AIDS research, programs,
funding and policy: researchers, program managers, donors, policy
makers, advocates, and other public figures.
We searched online information products–published research,
conference presentations, grants, media digests, and lists of key
staff/directors of major HIV and AIDS organizations–to identify
and create a list of key HIV/AIDS stakeholders. To ensure that
developing country stakeholders were included, we supplemented
our global searches with additional searches in six countries:
Kenya, Nigeria, Uganda, South Africa, Tanzania, and India.
To identify key researchers, we searched online journals (via
PubMed and Popline databases), conference presentations, and
NIH grants. Due to the high volume of HIV researchers listed in
PubMed, we chose to add individuals to the list only if they had
published research on PMTCT.
TofindkeyHIVprogramplannersandmanagers,wesearchedfor
organizationsimplementingworkfundedbytheBill&MelindaGates
Foundation, the President’s Emergency Plan for AIDS Relief
(PEPFAR), the World Bank, and the Global Fund for AIDS,
Tuberculosis and Malaria (GFATM). We added principal grant
recipients, team leaders, and others in leadership positions to the list.
To identify public figures in HIV/AIDS that may not have been
found in our other searches, we reviewed two years of Kaiser Daily
HIV/AIDS Reports (an email newsletter and online digest). To
narrow down the list of individuals included in these news reports,
we only added individuals to the list if they were mentioned or
quoted in a news summary about PMTCT, and we excluded
current heads of state.
Finally, we conducted internet searches to find lists of managers,
directors,and other high-level staff at major global HIV/AIDS donor
organizations and normative bodies (GFATM; World Bank; WHO;
UNAIDS; PEPFAR; Elizabeth Glaser Pediatric AIDS Foundation;
and the Bill & Melinda Gates Foundation), and the leaders and
members of major international HIV and AIDS task forces, working
groups, research organizations, and advocacy organizations (The
Global HIV Prevention Working Group; International AIDS
Alliance; the African Medical and Research Foundation [AMREF];
The American Foundation for AIDS Research [amfAR]; the Center
for HIV-AIDS Vaccine Immunology [CHAVI]; and the National
Institute of Allergyand Infectious Diseases [NIAID]). We included all
of these global leaders in our list.
Key informant interviews
Selection of interviewees. For the process of both
identifying interviewees and deciding whom to target with
individualized messages about contraception for HIV prevention
(i.e., the communications intervention), we sought to narrow down
the larger list to identify the most influential leaders. To select these
individuals, we used stratified purposive sampling [26].
To ensure that key informants represented the views of the larger
group that we identified, we based our selections on the overall
Figure 1. WHO/UNAIDS strategy for the prevention of mother-to-child transmission of HIV (see [1]). Triangle added for emphasis by
Family Health International.
doi:10.1371/journal.pone.0010781.g001
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and country-level lists. Furthermore, we wanted the interview
responses to reflect the range of individual characteristics and societal
roles of these opinion leaders, so we selected individuals who
represented a variety of organizations and institutions (maximum
variation sampling). Finally, individuals who appeared in more than
one data search were included in our list of interviewees (intensity
sampling). We hypothesized that these individuals would be
‘‘information-rich,’’ and would have detailed knowledge of the topic
[26,27]. They appeared in multiple data searches which suggests that
they have multiple spheres of influence, and thus could provide
valuable insights into what types of messaging would be effective for a
communications and advocacy campaign.
We selected forty-eight individuals for interviews based on these
maximum variation and intensity sampling techniques. However,
due to the high-profile–and thus hard-to-reach–status of some of
the individuals on our list, we narrowed this list down further to 24
individuals on the list who were known by colleagues, were easily
reachable, or otherwise the most likely to respond (opportunistic
sampling) [28]. We conducted in-depth interviews with 22 out of
24 individuals who responded.
Interview format and analysis. We conducted semi-
structured qualitative interviews in English, either in person or
by phone. Interviews ranged from 10 minutes to 30 minutes in
length. All interviews were tape recorded and then transcribed
verbatim. Participants were not reimbursed or given any
incentives for participating in interviews.
Each interview explored the following topics:
N The participant’s general opinion about contraception for
PMTCT
N Any professional work he/she was currently doing that
supported contraception for PMTCT
N What resources his/her organization might need to more
actively support implementation of such activities
N What factors he/she believed could facilitate or provide a
more prominent place for contraception among PMTCT
efforts
N What objections he/she has perceived among those who do not
support integrating contraceptive services into HIV prevention
and PMTCT efforts
N Who he/she thought could have a strong influence over others
if they were to promote contraception for the prevention of
HIV
N Where he/she accesses information about HIV and/or
contraception, and which communication channels most
influence his/her decisions
All parts of the interviews were reviewed, but we focused our
coding and analysis on: opinions about contraception for
PMTCT; opinions about barriers/facilitators of implementing
integrated family planning/HIV services; and communication
channels.
Two analysts read through several transcripts and indepen-
dently identified a list of emerging ideas, which they grouped into
12 broad themes. The two individuals worked together to develop
a codebook. Each theme was given a code. They independently
coded each transcript. Due to the small data set, the analysts coded
the data by hand and no software was used. Using an iterative
process, they altered the codebook as new themes emerged.
The two individuals met to compare how they coded each
transcript. Any discrepancies between the two coders were
resolved through discussion. Since all discrepancies were resolved,
no inter-reliability metrics were needed. The analysts calculated
the total number of interviews in which each theme was
mentioned (for the entire sample), and then compiled separate
totals for country-level and global-level interviews. They also
performed a thematic analysis of the interviews, examining the
major themes and ideas that arose in each interview [28],
including an analysis of the differences between the answers of
interviewees working at the country level and those working at the
global level. Finally, they ran frequencies for the question about
information and communication channels.
Results
Stakeholder Identification
Through our searches we generated a list of 467 HIV
stakeholders. All of our target groups for the future communica-
tions intervention were represented in this list: researchers,
program managers, policymakers, donors, advocates, and other
public figures. Forty-eight percent were based in Africa, 28% in
North America, 13% in Europe, 10% in Asia, 0.6% in Latin
America and the Caribbean, and 0.4% in Australia.
The number of stakeholders identified by each of our data
search methods is shown in Table 1.
Key informant interviews
After applying stratified purposive sampling, forty-eight indi-
viduals were eligible to be interviewed. The 22 interviewees chosen
were the most accessible and available. The geographic distribu-
tion of the 22 key informants (12 from Africa; 9 from the US; 1
from Europe) and the male to female ratio (15 male; 7 female)
were similar to the broader group of stakeholders. The group of
interviewees included 11 researchers and scientists, 5 national-level
health officials, 3 international donors, 2 advocates, and 1
Table 1. Number of stakeholders found by data search.
Data Search # of stakeholders found
Published research, conference presentations, NIH PMTCT grants 117
HIV program planners and managers (Global Fund, PEPFAR, World Bank, Gates Foundation) 131
Kaiser Daily HIV/AIDS Reports 31
Leadership of major HIV/AIDS organizations, normative bodies, international task forces,
working groups, research organizations and advocacy groups
218
(Note: The sum equals a higher number than the final stakeholder total due to several individuals who appeared in more than one of the four searches. The total
number of stakeholders was reached after removing duplicate individuals.)
doi:10.1371/journal.pone.0010781.t001
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Global HIV Prevention Working Group.
Although we asked about participants’ perceptions of contra-
ception as a PMTCT strategy, respondents often talked about
family planning and HIV/AIDS integration more broadly since
strengthening linkages between the two is how contraception for
HIV prevention is typically operationalized (in addition to
generally strengthening family planning programs for all women
in high HIV prevalence settings) [29]. Although we asked about
both barriers to and facilitators for implementing family planning
as HIV prevention, the responses we received focused on the
former.
Table 2 summarizes the themes related to barriers to
implementing family planning/HIV integration that emerged
from the interviews and the number of stakeholders who
mentioned each theme. This table presents the results for all
respondents together, and also offers a comparison of the themes
emerging from country-level and global-level stakeholders’ inter-
views; we classified 10 interviewees as working primarily at the
global level, and 12 as working primarily at the country level.
Overall, the most common theme in the interviews was a ‘lack
of resources to link family planning and HIV/AIDS services’,
which was mentioned as a barrier to implementing integrated
family planning and HIV/AIDS services by 20 participants.
Interviewees usually used the term ‘‘resources’’ to refer to funding
for services generally (either family planning or HIV/AIDS);
however, human resources, contraceptive commodities, and clinic
supplies were also discussed.
Many participants mentioned that while HIV programs may
benefit from integrating family planning with other clinical
services, the overall lack of funding for existing services makes
implementation difficult. As the director of one infectious disease
institute in Africa explained, ‘‘[A]lthough we want to incorporate it
[family planning] into a [HIV/AIDS] clinic we would need…additional
staff to help in the clinics where they don’t have enough resources for anything.’’
One HIV researcher said, ‘‘Organizations follow the money,’’ so the
most effective way to strengthen linkages between family planning
and HIV is to ‘‘encourage funding organizations to make this a priority.’’
The second most common theme, discussed by 18 participants,
was the ‘lack of infrastructure or capacity to provide integrated
services at the facility level’. Each of these interviewees appreciated
the need for the provision of both HIV and family planning
services within the same physical structure. Most participants listed
specific constraints that prevent this from being a norm. One
senior AIDS official from a ministry of health in East Africa said,
‘‘We need support in training health workers to give them skills, but also for
supervision to make sure that integration is properly done, especially
maintaining the quality of care.’’ This lack of training and support
for health workers was mentioned often as an obstacle to
implementing integrated family planning/HIV programming.
An interviewee from Uganda said, ‘‘Capacity building and training
the service providers to be able to handle these services [is needed]…if it is the
same health worker who is providing counseling and services for HIV
prevention, and he or she is trained in family planning services, then integration
becomes easy.’’
Sixteen participants discussed the ‘lack of national-level
leadership or coordination’ as a barrier. A participant from
Uganda said, ‘‘There is need for leadership to be able to guide the integration
process so that if you mobilize resources for–say–HIV/AIDS, then the
leadership should be on board in terms of guiding this money… to advance the
cause of family planning.’’ Some informants proposed that more
national coordination or ‘‘ownership’’ of the issue from ministries
of health and other national officials could improve implementa-
tion by providing a platform on which to build bridges between
family planning and HIV programs and carry out existing
supportive policies. Another interviewee from Uganda noted,
Table 2. Key interview findings by theme.
Theme
# of overall
informants
mentioning
theme (out of 22)
# of global-level
informants
mentioning
theme (out of 10)
# of country-level
informants
mentioning
theme (out of 12)
Lack of resources to link FP and HIV/AIDS services 20 9 11
Lack of infrastructure or capacity to provide integrated services at the facility level 18 7 11
Lack of national-level leadership or coordination 16 4 12
Lack of targeted advocacy to decision-makers 16 7 9
Lack of knowledge and/or understanding of FP’s contributions to HIV prevention 15 7 8
Separation of or competing resources for FP and HIV/AIDS 15 8 7
Cultural or religious resistance to family planning 12 5 7
Family planning or HIV/AIDS program managers and service providers seeing the
responsibility as lying elsewhere
12 7 5
Separation of family planning and HIV/AIDS programs 12 8 4
Political resistance from decision-makers to family planning 10 4 6
Lack of global-level leadership or coordination 8 5 3
Lack of influential individuals as ‘champions’ 7 4 3
Separation of family planning and HIV/AIDS policies 7 3 4
Lack of monitoring and evaluation systems for integrated services 5 3 2
Indifference at policy or donor levels toward strengthening
linkages between FP and HIV/AIDS
312
Lack of visibility in published literature or technical conferences on the
benefits of integrating FP and HIV/AIDS services
330
doi:10.1371/journal.pone.0010781.t002
Contraception and PMTCT
PLoS ONE | www.plosone.org 4 May 2010 | Volume 5 | Issue 5 | e10781‘‘Advocacy [is needed] within the Ministry of Health itself ultimately. It is
the Ministry of Health who are responsible for health care.’’
A ‘lack of targeted advocacy to key decision-makers’ was also
mentioned by sixteen participants. They noted the need for
advocacy aimed at stakeholders across the spectrum, including
global policymakers, national program managers, and individual
service providers. Many participants recommended that advocacy
be targeted at international donors, including a senior official from
an international foundation who said, ‘‘What it is going to take is some
advocacy to make it happen. I’m always optimistic that funding organizations
can be encouraged to do quite a bit. They are quite open to it, so I think it is
probably a matter of advocates getting them interested in it.’’
Fifteen participants mentioned ‘lack of knowledge and/or
understanding’ of contraception’s contributions to HIV prevention
and the benefits of family planning/HIV integration among all
levels of stakeholders as a barrier. Most interviewees who
mentioned this linked it with the need for advocacy to remedy
the lack of understanding.
The separate funding streams for family planning and HIV/
AIDS programming and services, from donors and within national
governments, were also mentioned by fifteen participants as a
barrier to integrated service provision. ‘‘Often what happens, because
the funding streams are somewhat artificially divided, is health care personnel
are trained in HIV/AIDS prevention care or treatment and then they are
trained, perhaps separately, around family planning. … The training cycles are
not integrated,’’ said the top official at an international HIV/AIDS
foundation. This challenge was often described as a reason why
program planners are not able to design comprehensive services,
and also as a contributor to overlapping efforts and inefficient use
of resources. With regard to strict HIV programming, an HIV
researcher explained that the prevailing thinking is ‘‘This is an HIV
initiative, not a family planning initiative, and we are not going to use HIV
money for these other things. This does not make any sense because if [family
planning] has an HIV impact then it should be required of an HIV
program.’’
Further, some participants suggested that this separation of
resources may be the cause of competition or tension between the
reproductive health and HIV/AIDS fields over which programs
are responsible for what services, especially when resources are not
available to create bi-directional integrated programs. This was
illustrated when a staffer at WHO stated, ‘‘There is a tendency… [in]
some parts of the HIV community to see their primary area of work as being
rather more narrowly defined HIV services, and saying, ‘Family planning is
important, sure, but that’s not our responsibility.’ …you’ll find that
reproductive health people are struggling with family planning service generally
and they kind of feel like they don’t have the means [to offer HIV services]
…if a woman has HIV, programs are available and they are so well resourced
so surely they [HIV providers] should be doing it.’’
Overall, similar themes were mentioned by both country-level
and global stakeholders (see Table 2). However, we found some
differences in what the two groups identified as important.
Those working at the global level focused more on macro-level
funding, global policy and overall trends than did interviewees
working at the country level. The theme ‘separation of family
planning and HIV/AIDS programming’ was more common in
these interviews than among the country-level participants. Global
stakeholders also pointed out the tendency of both family planning
and HIV/AIDS professionals to avoid responsibility for imple-
menting integrated programs (the theme ‘family planning or HIV/
AIDS program managers and service providers see the responsi-
bility as lying elsewhere’).
Compared to global level participants, country-level interview-
ees focused more on the specifics of implementing family planning
and HIV integration. The most common theme among this group
was the ‘lack of national leadership or coordination’, which was
mentioned by all country-level informants. Additionally, more
participants at the country-level than the global-level mentioned
the ‘lack of infrastructure or capacity to provide integrated services
at the facility level’ as a barrier to integrating family planning and
HIV programs.
Regarding which communications channels the participants use
to make decisions about HIV/AIDS research, funding, policy, or
programming, all 22 key informants said that they take into
account information received at meetings and conferences; 18 of
the 22 responded that they use information from print
publications, online publications, and other colleagues; 17
informants said that they use information found in emails; and
10 said the same for listservs (though listservs and email were both
more important to those working at the global level than at the
country level). Television and radio were not seen as important
sources of information for the majority of the participants. In
response to a question about which information source most
influences their decisions, 15 of the 22 interviewees said either
print or online publications; 7 individuals stated that conferences/
meetings were the most important source of information for them.
Discussion
Funding for HIV/AIDS continues to increase [30] as donor
assistance for family planning essentially stagnates and continues
to fall short of meeting needs [31]. At the same time, despite
continued growth in international policy support for linking family
planning and HIV/AIDS, parallel funding streams and program-
ming structures persist at the global and national levels [32]. This
has largely remained the case despite clear evidence of the
effectiveness and cost-efficiency of contraception’s contributions to
PMTCT. Indeed, the current narrow focus of PMTCT programs
is only one example of how disease-specific global health funding,
particularly for HIV/AIDS, can exacerbate the verticalization of
recipient countries’ health systems [33]. With limited human and
financial resources to establish or strengthen a primary care model
and improve the capacity of health care workers to provide
comprehensive care packages (such as integrated family planning
and HIV/AIDS), and without strong national or donor mandates
to do so, programs continue struggling to deliver integrated
services.
The results of our key informant interviews with opinion leaders
in HIV/AIDS substantiated these barriers and constraints.
Regardless of their professional affiliation, most of the stakeholder
informants told us the biggest challenges to implementing element
2 of WHO’s PMTCT strategy were restricted or siloed funding
and the need to improve health infrastructure and human capacity
to provide better services. It is worth noting that our interviews
took place in 2008, before the U.S. presidential election and
subsequent administration change. Since that time, a growing
number of USAID bilateral agreements are encouraging integra-
tion by combining funding for HIV/AIDS and family planning
into single health programs, and global HIV/AIDS funding
mechanisms like PEPFAR and the Global Fund are becoming
increasingly supportive of family planning services as essential
components of HIV/AIDS programs.
During our interviews, participants recommended directing
more advocacy at international donors to counter the lack of and
parallel nature of family planning and HIV/AIDS funding, As the
funding environment continues to improve, however, advocacy
and communication campaigns will eventually need to shift toward
national decision-makers and program planners to improve their
ability to leverage these new and less restrictive funding
Contraception and PMTCT
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pants suggested that countries take more ownership over the issue
of harmonizing planning for funding, programming and training
structures between the two fields. The importance of establishing
close partnerships between the family planning and HIV/AIDS
sectors was mentioned by several interviewees as a way to
overcome the challenges of parallel programming.
Few participants mentioned the ‘lack of visibility in published
literature or technical conferences’ as a main reason why this HIV
prevention strategy has not been more prominent. At the same
time, the theme of ‘lack of knowledge and understanding’ came up
frequently, suggesting that the evidence regarding family plan-
ning’s contribution to HIV prevention does in fact need to be
disseminated more broadly. Furthermore, as the evidence base for
effective models of family planning and HIV/AIDS integration
continues to grow, research findings should be accompanied by
guidance documents [34] and targeted technical support so
stakeholders are able to enact evidence-based policy and
programmatic changes. Dissemination of such evidence and
guidance is a key component of targeted advocacy for decision-
makers (a need cited by key informants), and such an effort should
ensure a presence in key print publications, as well as online
resources, as most of the interviewees noted that these are the
resources that most influence their decision-making.
Interestingly, both global-level and country-level participants
tended to defer accountability to others, electing not to assume
responsibility themselves for promoting access to contraception as
a core element of PMTCT. All of the participants acknowledged
the role of family planning in HIV prevention, yet most
simultaneously asserted that their professional focus lay elsewhere
and that taking action to increase access to contraception for
PMTCT was not within their current purview. At the same time,
many interviewees mentioned the potential impact of having
notable individuals–presumably people like themselves–champion
the issue, serving as catalysts for an organized and multi-sector
response.
It is also worth mentioning that although, perhaps surprisingly,
none of the key informants highlighted this issue as a barrier, there
is a critical need to improve the access to and quality of current
national family planning programs (integrated or otherwise) in
low- and middle-income countries. Particularly for low HIV
prevalence areas, and in light of the fact that many women remain
unaware of their HIV status in both low and high prevalence
areas, we would argue that making improvements in family
planning services for the general population may better contribute to
meeting the contraceptive needs of HIV-positive women (and by
extension reducing MTCT) than will integrating a poor quality
family planning program with HIV services.
On a final note, the systematic stakeholder mapping approach
we used filtered substantial amounts of information to arrive at a
relatively small but comprehensive list (considering the volume of
individuals working in HIV/AIDS) of professionally and geo-
graphically diverse individuals who play key roles in HIV/AIDS
research, funding, policy and programming. Even the rigorous,
systematic approach we used to identify individual stakeholders,
however, has limitations and likely still missed ‘‘key players.’’
Others using this approach might consider supplementing their
searches opportunistically–for example, by incorporating the tacit
knowledge available through staff or from key informants, or by
identifying a cohort via existing pre-vetted coalitions or working
groups.
Conclusion
Preventing unintended pregnancies in HIV-infected women is a
proven PMTCT approach and therefore an essential component
of a comprehensive PMTCT program. A diverse set of individuals
have regional or international influence in the field of HIV, and
the challenge of strengthening the implementation of contracep-
tion for HIV prevention is complex. Our findings affirm the
existence of a multi-layered set of barriers and offer recommen-
dations for addressing several of the primary challenges.
Harnessing the influence of key individuals–to launch strength-
ened education, advocacy, and research efforts, as well as to
support evolving funding mechanisms and policy structures–will
be a necessary first step toward affecting measurable change.
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